Have a personal or library account? Click to login
Toll-Like Receptors and their Contribution to Innate Immunity: Focus on TLR4 Activation by Lipopolysaccharide Cover

Toll-Like Receptors and their Contribution to Innate Immunity: Focus on TLR4 Activation by Lipopolysaccharide

Medical Journal of Cell Biology
Volume 4 (2014): Issue 1 (March 2014)
By: Maciej Czerkies and  Katarzyna Kwiatkowska  
Open Access
|Oct 2014

References

  1. [1] Anderson KV, Nüsslein-Volhard C. Information for the dorsal-ventral pattern of the Drosophila embryo is stored as maternal mRNA. Nature 1984; 311: 223-227.10.1038/311223a06434989
    Search in Google Scholar
  2. [2] Baranova IN, Kurlander R, Bocharov AV, Vishnyakova TG, Chen Z, Remaley AT, Csako G, Patt erson AP, Eggerman TL. Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signalling. J Immunol 2008; 181: 7147-7156.10.4049/jimmunol.181.10.7147384222318981136
    Search in Google Scholar
  3. [3] Bianchi Me. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81: 1-5.10.1189/jlb.030616417032697
    Search in Google Scholar
  4. [4] Bortoluci KR, Medzhitov R. Control of infection by pyroptosis and autophagy: role of TLR and NLR. Cell Mol Life Sci 2010; 67: 1643-1651.10.1007/s00018-010-0335-520229126
    Search in Google Scholar
  5. [5] Carty M, Goodbody R, Schroder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signalling. Nat Immunol 2006; 7: 1074-1081.10.1038/ni138216964262
    Search in Google Scholar
  6. [6] Chiang CY, Veckman V, Limmer K, Dav id M. Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J Biol Chem 2012; 287: 3704-3709.10.1074/jbc.C111.328559328173322158869
    Search in Google Scholar
  7. [7] Choe J, Kelker MS, Wilson IA. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 2005; 309: 581-585.10.1126/science.111525315961631
    Search in Google Scholar
  8. [8] Duerr CU, Zenk SF, Chassin C, Pott J, Gutle D, Hensel M, Hornef MW. O-antigen delays lipopolysaccharide recognition and impairs antibacterial host defense in murine intestinal epithelial cells. PLoS Pathog 2009; 5: e1000567.10.1371/journal.ppat.1000567272992819730692
    Search in Google Scholar
  9. [9] Dunzendorfer S, Lee HK, Soldau K, Tobias PS. TLR4 is the signalling but not the lipopolysaccharide uptake receptor. J Immunol 2004; 173: 1166-1170.10.4049/jimmunol.173.2.116615240706
    Search in Google Scholar
  10. [10] Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants? J Leukoc Biol 2010; 87: 989-999.10.1189/jlb.120977520179153
    Search in Google Scholar
  11. [11] Erridge C, Bennett-Guerrero E, Poxton IR. Structure and function of lipopolysaccharides. Microbes Infect 2002; 4: 837-851.10.1016/S1286-4579(02)01604-0
    Search in Google Scholar
  12. [12] Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leukoc Biol 1998; 64: 25-32.10.1002/jlb.64.1.259665271
    Search in Google Scholar
  13. [13] Fitzgerald KA, Mcwhirter SM, Faia Kl, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniat is T. IKKε and TBK1 are essential components of the IRF3 signalling pathway. Nat Immunol 2003; 4: 491-496.10.1038/ni92112692549
    Search in Google Scholar
  14. [14] Gay NJ, Gangloff M. Structure and function of Toll receptors and their ligands. Annu Rev Biochem 2007; 76: 141-165.10.1146/annurev.biochem.76.060305.15131817362201
    Search in Google Scholar
  15. [15] Gay NJ, Gangloff M, O’neill LA. What the Myddosome structure tells us about the initiation of innate immunity. Trends Immunol 2011; 32: 104-109.10.1016/j.it.2010.12.00521269878
    Search in Google Scholar
  16. [16] Grygorowicz MA, Kozłowska E. Involvement of TLR receptors recognising pathogens’ molecular patterns in modulation of activity manifested by regulatory lymphocytes T CD4+CD25+FoxP3+(in Polish). Post. Mikrobiol 2011; 50: 141-154.
    Search in Google Scholar
  17. [17] Hasan UA, Dollet S, Vlach J. Differential induction of gene promoter constructs by constitutively active human TLRs. Biochem Biophys Res Commun 2004; 321: 124-131.10.1016/j.bbrc.2004.06.13415358224
    Search in Google Scholar
  18. [18] Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S, Guiet C, Briere F, Vlach J, Lebecque S, Trinchieri G, Bat es EE. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005; 174: 2942-2950.10.4049/jimmunol.174.5.294215728506
    Search in Google Scholar
  19. [19] Haworth R, Platt N, Keshav S, Hughes D, Darley E, Suzuki H, Kurihara Y, Kodama T, Gordon S. The macrophage scavenger receptor type A is expressed by activated macrophages and protects the host against lethal endotoxic shock. J Exp Med 1997; 186: 1431-1439.10.1084/jem.186.9.143121991239348300
    Search in Google Scholar
  20. [20] Horng T, Barton GM, Medzhitov IR. TIRAP: an adapter molecule in the Toll signalling pathway. Nat Immunol 2001; 2: 835-841.10.1038/ni0901-83511526399
    Search in Google Scholar
  21. [21] Huber M, Kalis C, Keck S, Jiang Z, Georgel P, Du X, Shamel L, Sovat h S, Mudd S, Beutler B, Galanos C, Freudenberg MA. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur J Immunol 2006; 36: 701-711.10.1002/eji.20053559316506285
    Search in Google Scholar
  22. [22] Husebye H, Halaas O, Stenmark H, Tunheim G, Sandanger O, Bogen B, Brech A, Latz E, Espevik T. Endocytic pathways regulate Toll-like receptor 4 signalling and link innate and adaptive immunity. EMBO J 2006; 25: 683-962.10.1038/sj.emboj.7600991138356916467847
    Search in Google Scholar
  23. [23] Husebye H, Aune Mh, Stenvik J, Samsta d E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, Mollnes TE, Bakke O, Espevik T. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 2010; 33: 583-596.10.1016/j.immuni.2010.09.01020933442
    Search in Google Scholar
  24. [24] Iwasaki A, Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010; 327: 291-295.10.1126/science.1183021364587520075244
    Search in Google Scholar
  25. [25] Jiang Z, Georgel P, Du X, Shamel L, Sovat h S, Mudd S, Huber M, Kalis S, Keck S, Galanos C, Freudenberg M, Beutler B. CD14 is required for MyD88-independent LPS signalling. Nat Immunol 2005; 6: 565-570.10.1038/ni120715895089
    Search in Google Scholar
  26. [26] Jin Ms, Lee Jo. Structures of the toll-like receptor family and its ligand complexes. Immunity 2008; 29: 182-191.10.1016/j.immuni.2008.07.00718701082
    Search in Google Scholar
  27. [27] Jin MS, Kim SE, Heo JY, Lee ME, Kim HM, Paik SG, Lee H, Lee JO. Crystal structure of the TLR1- TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 2007; 130: 1071-1082.10.1016/j.cell.2007.09.00817889651
    Search in Google Scholar
  28. [28] Józefowski S. The role of the class A scavenger receptors, SR-A and MARCO, in the immune system. Part 1. The structure of receptors, their ligand binding repertoires and ability to initiate intracellular signalling. Postepy Hig Med Dosw (Online) 2012; 6: 104-119.
    Search in Google Scholar
  29. [29] Kagan JC, Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signalling. Cell 2006; 125: 943-955.10.1016/j.cell.2006.03.04716751103
    Search in Google Scholar
  30. [30] Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat Immunol 2008; 9: 361-368. 10.1038/ni1569411282518297073
    Search in Google Scholar
  31. [31] Kang JY, Lee JO. Structural biology of the Toll-like receptor family. Annu Rev Biochem 2011; 80: 917-941.10.1146/annurev-biochem-052909-14150721548780
    Search in Google Scholar
  32. [32] Kang JY, Nan X, Jin MS, Youn SJ, Ryu JH, Mah S, Han SH, Lee H, Paik SG, Lee JO. Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 2009; 31: 873-884.10.1016/j.immuni.2009.09.01819931471
    Search in Google Scholar
  33. [33] Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signalling. Ann N Y Acad Sci 2008; 1143: 1-20.10.1196/annals.1443.020
    Search in Google Scholar
  34. [34] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010; 11: 373-384.10.1038/ni.1863
    Search in Google Scholar
  35. [35] Kennedy MN, Mullen GE, Leifer CA, Lee C, Mazzoni A, Dileepa n KN, Segal DM. A complex of soluble MD-2 and lipopolysaccharide serves as an activating ligand for Toll-like receptor 4. J Biol Chem 2004; 279: 34698-34704.10.1074/jbc.M405444200
    Search in Google Scholar
  36. [36] Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC, Enkhbayar P, Mat sushima N, Lee H, Yoo OJ, Lee JO. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007; 130: 906-917.10.1016/j.cell.2007.08.002
    Search in Google Scholar
  37. [37] Kim JI, Lee CJ, Jin MS, Lee CH, Paik SG, Lee H, Lee JO. Crystal structure of CD14 and its implications for lipopolysaccharide signalling. J Biol Chem 2005; 280: 11347-11351.10.1074/jbc.M414607200
    Search in Google Scholar
  38. [38] Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001; 11: 725-732.10.1016/S0959-440X(01)00266-4
    Search in Google Scholar
  39. [39] Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol 2011; 30: 16-34.10.3109/08830185.2010.529976
    Search in Google Scholar
  40. [40] Leelahava nichkul A, Bocharov AV, Kurlander R, Baranova IN, Vishnyakova TG, Souza AC, Hu X, Doi K, Vaisman B, Amar M, Sviridov D, Chen Z, Remaley AT, Csako G, Patt erson AP, Yuen PS, Sta r RA, Eggerman TL. Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J Immunol 2012; 188: 2749-2758.10.4049/jimmunol.1003445
    Search in Google Scholar
  41. [41] Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996; 86: 973-983.10.1016/S0092-8674(00)80172-5
    Search in Google Scholar
  42. [42] Leulier F, Lemaitre B. Toll-like receptors - taking an evolutionary approach. Nat Rev Genet 2008; 9: 165-178.10.1038/nrg230318227810
    Search in Google Scholar
  43. [43] Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 2010; 465: 885-890.10.1038/nature09121288869320485341
    Search in Google Scholar
  44. [44] Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010; 327: 46-50.10.1126/science.117462120044567
    Search in Google Scholar
  45. [45] Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, Dav ies DR. Structural basis of toll-like receptor 3 signalling with double-stranded RNA. Science 2008; 320: 379-381.10.1126/science.1155406276103018420935
    Search in Google Scholar
  46. [46] Macleod H, WETZLER LM. T cell activation by TLRs: a role for TLRs in the adaptive immune response. Sci STKE 2007; 2007(402): e48.10.1126/stke.4022007pe4817785715
    Search in Google Scholar
  47. [47] Mat sushima N, Tanaka T, Enkhbayar P, Mikami T, Taga M, Yamada K, Kuroki K. Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors. BMC Genomics 2007; 8: 124.10.1186/1471-2164-8-124189918117517123
    Search in Google Scholar
  48. [48] Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388: 394-397.10.1038/411319237759
    Search in Google Scholar
  49. [49] Meng J, Parroche P, Golenbock DT, Mck night CJ. The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14. J Biol Chem 2008; 283: 3376-33784.10.1074/jbc.M70764020018057002
    Search in Google Scholar
  50. [50] Mishra BB, Gundra UM, Teale JM. Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis. J Neuroinflammation 2008; 5: 53. 10.1186/1742-2094-5-53263147719077284
    Search in Google Scholar
  51. [51] Mukhopa dhyay S,Varin A, Chen Y, Liu B, Tryggva son K, Gordon S. SRA/MARCO-mediated ligand delivery enhances intracellular TLR and NLR function, but ligand scavenging from cell surface limits TLR4 response to pathogens. Blood 2011; 117: 1319-1328.10.1182/blood-2010-03-27673321098741
    Search in Google Scholar
  52. [52] Nagai Y Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kita mura T, Kosugi A, Kimoto M, Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3: 667-672.10.1038/ni80912055629
    Search in Google Scholar
  53. [53] Nunez Miguel R, Wong J, Westoll JF, Brooks HJ, O’neill LA, Gay NJ, Bryant CE, Monie TP. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS One 2007; 2: e788.10.1371/journal.pone.0000788194508317726518
    Search in Google Scholar
  54. [54] Nyman T, Stenmark P, Flodin S, Johansson I, Hammarstrom M, Nordlund P. The crystal structure of the human Toll-like receptor 10 cytoplasmic domain reveals a putative signalling dimer. J Biol Chem 2008; 283: 11861-11865.10.1074/jbc.C80000120018332149
    Search in Google Scholar
  55. [55] Ohto U, Fukase K, Miyake K, Sat ow Y. Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 2007; 316: 1632-1633.10.1126/science.113911117569869
    Search in Google Scholar
  56. [56] Panter G, Jerala R. The ectodomain of the Toll-like receptor 4 prevents constitutive receptor activation. J Biol Chem 2011; 286: 23334-13344.10.1074/jbc.M110.205419312309821543336
    Search in Google Scholar
  57. [57] Park BS, Song DH, Kim HM, Choi BS, Lee H, Lee JO. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009; 458: 1191-1195.10.1038/nature0783019252480
    Search in Google Scholar
  58. [58] Pifer R, Benson A, Sturge CR, Yarovinsky F. UNC93B1 is essent ial for TLR11 act ivat ion and IL-12-dependent host resistance to Toxoplasma gondii. J Biol Chem 2011; 286: 3307-3314.10.1074/jbc.M110.171025303033621097503
    Search in Google Scholar
  59. [59] Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi Castag noli P, Layton B, Beutler B. Defective LPS signalling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.10.1126/science.282.5396.20859851930
    Search in Google Scholar
  60. [60] Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002; 71: 635-700.10.1146/annurev.biochem.71.110601.135414256985212045108
    Search in Google Scholar
  61. [61] Resman N, Vasl J, Oblak A, Pristovsek P, Gioannini TL, Weiss JP, Jerala R. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin. J Biol Chem 2009; 284: 15052-15060.10.1074/jbc.M901429200268568719321453
    Search in Google Scholar
  62. [62] Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zahringer U, Seydel U, Di Padova F, Schreier M, Brade H. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8: 217-225.10.1096/fasebj.8.2.81194928119492
    Search in Google Scholar
  63. [63] Rittig MG, Kaufmann A, Robins A, Shaw B, Sprenger H, Gemsa D, Foulongne V, Rouot B, Dornand J. Smooth and rough lipopolysaccharide phenotypes of Brucella induce different intracellular trafficking and cytokine/chemokine release in human monocytes. J Leukoc Biol 2003; 74: 1045-1055.10.1189/jlb.010301512960272
    Search in Google Scholar
  64. [64] Rolls A, Shechter R, London A, Ziv Y, Ronen A, Levy R, Schwartz M. Toll-like receptors modulate adult hippocampal neurogenesis. Nat Cell Biol 2007; 9: 1081-1088.10.1038/ncb162917704767
    Search in Google Scholar
  65. [65] Salomao R, Brunialti MK, Rapozo MM, Baggio-Zappia GL, Galanos C, Freudenberg M. Bacterial sensing, cell signalling, and modulation of the immune response during sepsis. Shock 2012; 38: 227-242.10.1097/SHK.0b013e318262c4b022777111
    Search in Google Scholar
  66. [66] Sat oh T, Kat o H, Kumagai Y, Yoneyama M, Sat o S, Mat sushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O. LGP2 is a positive regulator of RIG-I and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 2010. 107: 1512-517.10.1073/pnas.0912986107282440720080593
    Search in Google Scholar
  67. [67] Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950.10.1038/ni71211547333
    Search in Google Scholar
  68. [68] Shibata T, Motoi Y, Tanimura N, Yamakawa N, Akashi-Takamura S, Miyake K. Intracellular TLR4/ MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes. Int Immunol 2011; 23: 503-510. 10.1093/intimm/dxr04421712422
    Search in Google Scholar
  69. [69] Silhav y TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol 2010; 2: a000414.10.1101/cshperspect.a000414285717720452953
    Search in Google Scholar
  70. [70] Sun J, Duffy KE, Ranjith-Kumar CT, Xiong J, Lamb RJ, Santos J, Masarapu H, Cunningham M, Holzenburg A, Sarisky RT, Mbow ML, Kao C. Structural and functional analyses of the human Toll- like receptor 3. Role of glycosylation. J Biol Chem 2006; 281: 11144-11151.10.1074/jbc.M51044220016533755
    Search in Google Scholar
  71. [71] Triantaf ilou M, Morat h S, Mackie A, Hartung K, Triantaf ilou K. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 2004; 117: 4007-4014.10.1242/jcs.0127015286178
    Search in Google Scholar
  72. [72] Triantaf ilou M, Lepper PM, Briault CD, Ahmed MA, Dmochowski JM, Schumann C, Triantaf ilou K. Chemokine receptor 4 (CXCR4) is part of the lipopolysaccharide “sensing apparatus”. Eur J Immunol 2008; 38: 192-203.10.1002/eji.20063682118081034
    Search in Google Scholar
  73. [73] Triantaf ilou M, Lepper PM, Olden R, Dias IS, Triantaf ilou K. Location, location, location: Is membrane partitioning everything when it comes to innate immune activation? Mediators Inflamm 2011; 2011: 186093.10.1155/2011/186093313410521765613
    Search in Google Scholar
  74. [74] Wang Y, Chen T, Han C, He D, Liu H, An H, Cai Z, Cao X. Lysosome-associated small Rab GTPase Rab7b negatively regulates TLR4 signalling in macrophages by promoting lysosomal degradation of TLR4. Blood 2007; 110: 962-971.10.1182/blood-2007-01-06602717395780
    Search in Google Scholar
  75. [75] Wang D, Lou J, Ouyang C, Chen W, Liu Y, Liu X, Cao X, Wang J, Lu L. Ras-related protein Rab10 facilitates TLR4 signalling by promoting replenishment of TLR4 onto the plasma membrane. Proc Natl Acad Sci USA 2010; 107: 13806-13811.10.1073/pnas.1009428107292228320643919
    Search in Google Scholar
  76. [76] Wang Y, Yang Y, Liu X, Wang N, Cao H, Lu Y, Zhou H, Zheng J. Inhibition of clathrin/dynamin-dependent internalization interferes with LPS-mediated TRAM-TRIF-dependent signalling pathway. Cell Immunol 2012; 274: 121-129.10.1016/j.cellimm.2011.12.00722341560
    Search in Google Scholar
  77. [77] Watt ers TM, Kenny EF, O’neill LA. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol Cell Biol 2007; 85: 411-419.10.1038/sj.icb.710009517667936
    Search in Google Scholar
  78. [78] Weber AN, Morse MA, Gay NJ. Four N-linked glycosylation sites in humantoll-like receptor 2 cooperate to direct efficient biosynthesis and secretion. J Biol Chem 2004; 279: 34589-34594.10.1074/jbc.M40383020015173186
    Search in Google Scholar
  79. [79] Weiss J. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide- binding protein (LBP): structure, function and regulation in host defence against Gram- negative bacteria. Biochem Soc Trans 2003; 31: 785-790.10.1042/bst031078512887306
    Search in Google Scholar
  80. [80] Wong SW, Kwon MJ, Choi AM, Kim HP, Nakahira K, Hwang DH. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009; 284: 27384-27392.10.1074/jbc.M109.044065278566719648648
    Search in Google Scholar
  81. [81] Xu Y, Tao X, Shen B, Horng T, Medzhitov R, Manley JL, Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.Nature, 2000; 408: 111-115.10.1038/3504060011081518
    Search in Google Scholar
  82. [82] Yamamoto M, Sat o S, Hemmi H, Uemat su S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signalling pathway. Nat Immunol 2003; 4: 144-1150. 10.1038/ni98614556004
    Search in Google Scholar
  83. [83] Yamamoto M, Okamoto T, Takeda K, Sat o S, Sanjo H, Uemat su S, Saitoh T, Yamamoto N, Sakurai H, Ishii KJ, Yamaoka S, Kawai T, Mat suura Y, Takeuchi O, Akira S. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signalling. Nat Immunol 2006; 7: 962-970.10.1038/ni136716862162
    Search in Google Scholar
  84. [84] Yang H, Hreggvidsdottir HS, Palmblad K, Wang H, Ochani M, Li J, Lu B, Chava n S, Rosas-Ballina M, Al-Abed Y, Akira S, Bierhaus A, Erladsson-Harris H, Abdersson U, Tracey KJ. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci USA 2010; 107: 11942-11947. 10.1073/pnas.1003893107290068920547845
    Search in Google Scholar
  85. [85] Zanoni I, Ostuni R, Marek LR, Barresi S, Barbalat R, Barton GM, Granucci F, Kagan JC. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011; 147: 868-880.10.1016/j.cell.2011.09.051321721122078883
    Search in Google Scholar
  86. [86] Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flav ell RA, Ghosh IS. A toll-like receptor that prevents infection by uropathogenic bacteria.Science 2004; 303: 1522-1526.10.1126/science.109435115001781
    Search in Google Scholar
  87. [87] Zhu X, Owen JS, Wilson MD, Li H, Griffiths GL, Thomas MJ, Hiltbold EM, Fessler MB, Parks JS. Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res 2010; 51: 3196-3206. 10.1194/jlr.M006486295256020650929
    Search in Google Scholar
DOI: https://doi.org/10.2478/acb-2014-0001 | Journal eISSN: 2544-3577
Journal RSS Feed
Language: English
Page range: 1 - 23
Published on: Oct 15, 2014
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Toll-like receptors,
signal transduction,
lipopolysaccharide,
sepsis,
innate immunity
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2014 Maciej Czerkies, Katarzyna Kwiatkowska, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 4 (2014): Issue 1 (March 2014)Next article